CUSIP 363225202COM NEWGALTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
96 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vanguard Group Inc | 2.29M | $9.52M | +40.9K | Added |
| 2 | Osaic Holdings, Inc. | 1.09M | $4.54M | −134.1K | Reduced |
| 3 | Blackrock, Inc. | 796.6K | $3.31M | −1.1K | Reduced |
| 4 | Marshall Wace, LLP | 602.1K | $2.50M |
| Added |
| 5 | Wealthspire Advisors, LLC | 602.0K | $2.50M | +122.5K | Added |
| 6 | Geode Capital Management, LLC | 598.1K | $2.49M | −35.0K | Reduced |
| 7 | Commonwealth Equity Services, LLC | 334.1K | $1.39M | +39.2K | Added |
| 8 | Lpl Financial LLC | 325.3K | $1.35M | −35.0K | Reduced |
| 9 | Goldman Sachs Group Inc | 307.2K | $1.28M | +285.2K | Added |
| 10 | Susquehanna International Group, LLP | 286.9K | $1.19M | −159.7K | Reduced |
See every fund holding Galectin Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders